Fig. 1
From: Arbaclofen in fragile X syndrome: results of phase 3 trials
Design of adult/adolescent (a) and child (b) phase III arbaclofen studies
Fig. 1 | Journal of Neurodevelopmental Disorders
From: Arbaclofen in fragile X syndrome: results of phase 3 trials
Design of adult/adolescent (a) and child (b) phase III arbaclofen studies